U.S. Capital Wealth Advisors, LLC
Position in SMMT — Summit Therapeutics Inc.
CIK 1808915
AUSTIN, TX
Position in SMMT
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$227,690
+$17,810 QoQ
Shares Held
12,009
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SMMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026U.S. Capital Wealth Advisors, LLC holds $11,669,198 across 6 Biotechnology names. SMMT ranks #4 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
24,537 | $8,118,557 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
66,780 | $2,173,021 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,432 | $1,106,420 | |
| 4 | SMMT |
Summit Therapeutics Inc.
This page
|
12,009 | $227,690 | |
| 5 | ALDX |
Aldeyra Therapeutics, Inc.
|
15,805 | $26,710 | |
| 6 | IKT |
Inhibikase Therapeutics, Inc.
|
10,000 | $16,800 |
All Filings in SMMT
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $227,690 | 12,009 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $209,880 | 12,000 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $247,920 | 12,000 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $255,892 | 12,025 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $231,962 | 12,025 | Shares | Sole | 2025-04-29 | |
| No filing history on record for this holder in this stock. | ||||||